Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM
Clinical trial NCT04471844 · COMPLETED
Trial details
- NCT number
- NCT04471844
- Sponsor
- NovoCure Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-08
- Primary completion
- 2026-02-19
- Enrollment
- 981
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.